Can you discuss the ESC Guidelines for LDL-C targets and the recent AHA Guidelines designating a target threshold of 70 mg/DL? Is this low enough? What is your recommendation for PCSK9 inhibition in the high-risk ACS patient who has undergone PCI?

Can you discuss the ESC Guidelines for LDL-C targets and the recent AHA Guidelines designating a target threshold of 70 mg/DL? Is this low enough? What is your recommendation for PCSK9 inhibition in the high-risk ACS patient who has undergone PCI?

Can you discuss the ESC Guidelines for LDL-C targets and the recent AHA Guidelines designating a target threshold of 70 mg/DL? Is this low enough? What is your recommendation for PCSK9 inhibition in the high-risk ACS patient who has undergone PCI?


Created by

 CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Interventional Cardiologist's Perspective

Presenter

Ulf Landmesser MD, FESC

Ulf Landmesser MD, FESC

Professor of Cardiology Medical Director, Department of Cardiology Charite University Hospital Berlin, Germany